SUBSCRIBE
SUBSCRIBE

Synexa Life Sciences

Synexa Life Sciences is a biomarker and bioanalytical lab CRO, specialising in the development, validation and delivery of a wide range of complex and custom-designed assays.

With a team of over 200 staff across three global laboratory locations; Manchester, Turku (Finland) and Cape Town, we provide innovative solutions to support our customers to achieve their clinical milestones.

Our main areas of expertise include biomarker identification and development, large and small molecule clinical bioanalysis, (soluble) biomarker analysis (utilising MSD, LC-MS/MS, ELISA, RIA, fluorescence and luminescence-based technologies), cell biology (including flow cytometry, ELISpot and Fluorospot) and genomic services to support clinical trials and translational studies.

We pride ourselves on our deep scientific expertise and ability to tackle complex problems, translating them into robust and reliable assays to support clinical trial sample analysis.

NEWS
Hand closing valve on a gas pipeline. Energy crisis consept. Vector illustration.
Immuno-oncology
ASCO: Akeso’s VEGF/PD-1 boosts lung cancer survival, relieving pressure on US partner Summit
Analysts, investors and partner Summit Therapeutics had all been keenly awaiting the overall survival update, after previous data from Akeso’s HARMONi-6 trial left them wanting.
May 31, 2026
 · 
3 min read
 · 
Annalee Armstrong
Laptop with envelope and document with exclamation mark on screen. Receive notification, alert message, warning, get e-mail, email, spam concepts. Flat design vector illustration
Manufacturing
Cracked gaskets and rust-like residues trigger FDA warning letter to Alchymars
FDA inspectors found Alchymars failed to adequately maintain equipment used to make active pharmaceutical ingredients for the U.S. market. Over-the-counter drugmakers GC America and Sato Pharmaceutical also received warning letters.
May 29, 2026
 · 
2 min read
 · 
Nick Paul Taylor
Vector graphic illustration of team of doctors diagnose human lung, Pulmonologist infographic
Immuno-oncology
Summit’s PD-1/VEGF to take center stage at ASCO, with wide impact for peers
As Summit Therapeutics’ Chinese partner prepares to reveal data for a key trial at ASCO, analysts consider the impact on rivals Merck, Bristol Myers Squibb and BioNTech.
May 29, 2026
 · 
4 min read
 · 
Annalee Armstrong
Pointing up with fingers number three. Close up, isolated on white background.
Cancer
Replimune gives cancer immunotherapy a third try after FDA leadership shakeup
Replimune’s resubmission for RP1 for melanoma comes amid the departures of FDA leaders in place at the time of the drug’s first two rejections, last summer and again in April.
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Businessman carrying a stopwatch on a progress bar illustrating last minute deadline to complete a business project
Regulatory
FDA delays verdict on Beren’s rare disease drug by three months
Beren Therapeutics is seeking approval in Neimann-Pick disease type C, an application the FDA was set to decide on by August 17. The new target action date is November 17.
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac
a 3D rendering of a capsule-shaped pill showcases the flag of United State of America and flag of China
China
Pfizer bets up to $10.5B in 12-candidate cancer collab with China’s Innovent
Pfizer continues its dealmaking spree by striking a back-heavy partnership with China’s Innovent Biologics to assemble a pipeline of antibody-based therapies for cancer.
May 29, 2026
 · 
2 min read
 · 
Tristan Manalac
Large group of people standing in long line
Job Trends
The long wait: biopharma job searches often take at least 6 months, BioSpace finds
More than half of biotech and pharma job seekers have been looking for their next opportunity for six months or longer, and more than a quarter have searched for over a year, according to a BioSpace LinkedIn poll. Job seekers share their frustrations.
May 28, 2026
 · 
3 min read
 · 
Angela Gabriel
Healthcare service, hospital website online search, wellness plan and insurance concept. Health, care and medical element icon symbols in magnifying glass lens on blue background with copy space.
Infectious disease
GSK, Ionis’ hepatitis B functional cure effectively eliminates virus in nearly 20% of patients
The antisense oligonucleotide was even more effective in patients with relatively low viral activity. More than one-quarter of these individuals had undetectable levels of the virus in the blood for at least six months after stopping treatment.
May 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Support. Businessman draws a line as a bridge to help employees cross the cliff. vector
Obesity
Kailera walks path paved by Lilly in post-IPO ‘catalyst-rich period’
Kailera Therapeutics is advancing a pipeline of weight loss medicines that mirrors Eli Lilly’s: an injectable GLP-1/GIP dual agonist like Zepbound, an oral GLP-1 like Foundayo and a triple-G therapy like retatrutide.
May 28, 2026
 · 
2 min read
 · 
Tristan Manalac
Load More
Visit website
Email Us
IN THE PRESS
Press Releases
Waters Sets a New Benchmark for Robustness and Sensitivity for High-Throughput Labs with the Xevo TQ Absolute XR Mass Spectrometer
June 2, 2025
 · 
4 min read
BioMidwest
Inotiv, Inc. Announces New Site Openings and Expansions Supporting Additional Capacity and Service Offerings
December 8, 2022
 · 
4 min read
Business
Parexel Announces Strategic Collaboration with Synexa Life Sciences and Drawbridge Health for COVID-19 Clinical Serology Testing Solution
November 2, 2020
 · 
4 min read
JOBS